New Orleans Pelicans player Zion Williamson has received a biologic injection to promote bone healing in a fracture in his right foot, according to the NBA.
Biologics
Two medtech companies have partnered to develop 3D-printed regenerative joint implants.
The FDA's clinical hold on Ortho RIT's Ortho-R drug has been lifted, according to a Dec. 13 news release.
Sioux Falls, S.D.-based Sanford Health launched a clinical trial examining the effectiveness of treating osteoarthritis with stem cells across five joints, Sioux Falls Business reported Dec. 8.
The California Institute for Regenerative Medicine has awarded a $5.5 million grant to a University of California Irvine professor to study the use of stem cells to treat chronic cervical spinal cord injury.
Advertisement
Over the past five years, the U.S. has seen a significant spike in the number of clinics advertising stem cell treatments, which claim to treat a range of orthopedic, neurological and autoimmune conditions, among others.
Theradaptive's Osteo-Adapt SP spinal fusion implant received the FDA's breakthrough medical device designation, according to a Nov. 19 news release.
Pacira Biosciences completed its acquisition of Flexion Therapeutics, according to a Nov. 19 news release.
Orthobiologics company Bioventus has signed a lease agreement to double its current operations and manufacturing space in Cordova, Tenn.
A spine biologics company's $100 million investment deal and six more key updates in regenerative medicine in the last two months: